Descriptive Statistics of Serum Concentrations of Cytokines, Lipopolysaccharides and Cardiac Troponin by Severity Stage in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).

Descriptive Statistics of Serum Concentrations of Cytokines, Lipopolysaccharides and Cardiac Troponin by Severity Stage in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).

<p>Descriptive Statistics of Serum Concentrations of Cytokines, Lipopolysaccharides and Cardiac Troponin by Severity Stage in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Maria C. Jugan (18928389) (author)
Beste egile batzuk:	Gabrielle A. Rands (22676472) (author), Joerg M. Steiner (6887384) (author), Natalia Cernicchiaro (783181) (author), Matthew C. Tanner (22676475) (author), Lillian M. Novotny (22676478) (author)
Argitaratua:	2025
Gaiak:	Medicine Microbiology Cell Biology Physiology Biotechnology Ecology Immunology Cancer Science Policy Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified muscle condition score linear regression models fisher exact test evaluate possible associations body condition score gastrointestinal barrier function inflammatory biomarkers based stage c disease gastrointestinal clinical signs lps ), interleukins including 25 dogs e ., il div >< p stage b2 disease gastrointestinal bacterial translocation group 2 ), mmvd stage severity gastrointestinal signs bacterial translocation b2 disease gastrointestinal microbiome inflammatory markers disease progresses cardiovascular disease group 2 group 1 xlink "> untreated mmvd twenty percent therapeutic targets study indicates study aimed spearman ’ six client serum lps serum lipopolysaccharide serum il potential relationship positively correlated owned dogs mmvd severity mmvd ). maybe even groups 1 findings warrant fecal scores enrolled prospectively echocardiographic diagnosis compare proportions compare lps
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak

Association between Exposures of Interest with Serum Lipopolysaccharide and Troponin Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
nork: Maria C. Jugan (18928389)
Argitaratua: (2025)

Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial:aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
nork: Maria C. Jugan (18928389)
Argitaratua: (2025)

Association between Exposures of Interest with Serum Cytokine Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
nork: Maria C. Jugan (18928389)
Argitaratua: (2025)

Structural Basis of Lipopolysaccharide Assembly by the Outer Membrane Translocon Holo-Complex
nork: Rémi Fronzes (427447)
Argitaratua: (2025)

Comparison of WPAI-GH and SF-36v2 scores between normal and severe groups classified by dysmenorrhea score.
nork: Maika Nariai (22676447)
Argitaratua: (2025)

Participant characteristics in the overall cohort and in groups classified by dysmenorrhea score.
nork: Maika Nariai (22676447)
Argitaratua: (2025)

Multiple regression analyses of factors associated with work productivity and QoL.
nork: Maika Nariai (22676447)
Argitaratua: (2025)

Comparison of work productivity and QoL between women with normal and severe dysmenorrhea scores.
nork: Maika Nariai (22676447)
Argitaratua: (2025)

Relationship between dysmenorrhea score and presenteeism, activity impairment, physical component summary (PCS), mental component summary (MCS), and role/social component summary (RCS) scores.
nork: Maika Nariai (22676447)
Argitaratua: (2025)

Medication-inclusive multivariable logistic regression for MAFLD.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Multivariable logistic regression models for MAFLD predictors.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Liver Stiffness and Fibrosis Grading by MAFLD Status.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Comparison of Non-invasive Liver Fibrosis Scores.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Demographic and Clinical Characteristics of Study Participants.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Proposed pathophysiological crosstalk between MAFLD and CKD.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Stratification of Liver Stiffness according to eGFR in the MAFLD group.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black).
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

eGFR in the study participants.
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years).
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years).
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years).
nork: Zienab M. Saad (22676502)
Argitaratua: (2025)

Comparison of hierarchical classifier performance among four machine learning models for the early-loss, intermediate-loss, and late/no-loss groups.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Comparison of multi-class classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Comparison of binary classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Comparison of performance of four machine learning models for long-term graft loss prediction.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Comparison of prediction performance with previously reported metrics.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Comparison of performance of four machine learning models for early graft loss prediction.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Predicting stratified groups in the validation cohort: (A) Workflows for the multi-class classification and hierarchical classification models are illustrated.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Stratification and characterization of groups showing different graft survival: (A) UMAP visualization of the stratified derivation cohort data based on the distance matrix from the RF clustering.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Prediction of early graft loss at the individual level and identification of crucial factors: (A) Survival curves for all patients who experienced graft loss are plotted.
nork: Raiki Yoshimura (22676573)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Characteristic Flavaglines with Therapeutic Potential for Ischemic Stroke from <i>Aglaia perviridis</i>
nork: Yan-Ping Zhang (432349)
Argitaratua: (2025)

Cannot write session to /tmp/vufind_sessions/sess_118tik9mtuusn2242s95lcp6du